« Previous
Next »
American Journal of Ophthalmology
Volume 138, Issue 6
, Pages
936-951
, December 2004
The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24
To access this article, please choose from the options below
The COMS has been sponsored by the National Eye Institute and National Cancer Institute, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, Maryland, through cooperative agreements EY06253, EY06257, EY06258, EY06260, EY06264, EY06265, EY06266, EY06268, EY06269, EY06270, EY06274, EY06275, EY06276, EY06279, EY06280, EY06282, EY06283, EY06284, EY06287, EY06288, EY06289, EY06291, EY06839, EY06843, EY06844, EY06848, EY06858, and EY06899. No member of the COMS Group has any pertinent financial interest.
PII: S0002-9394(04)00847-5
doi: 10.1016/j.ajo.2004.07.006
© 2004 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Ophthalmology
Volume 138, Issue 6
, Pages
936-951
, December 2004
